Human monoclonal antibodies targeting rabies glycoprotein have been proposed as a potential alternative to rabies immunoglobulin to neutralise rabies virus at the wound site until sufficient virus ...

The U.S. Food and Drug Administration on Thursday announced a new program to speed up construction and review of drug ...